AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT ISIN: ZAE000078416
(“AfroCentric”)
DEALING IN SECURITIES BY DIRECTORS OF A MAJOR SUBSIDIARY
In compliance with paragraphs 3.63 of the JSE Limited Listings Requirements, the Company hereby
discloses the following dealings in securities by directors of a major subsidiary of AfroCentric:
Name of Director Aklaaq Mahmood
Designation: Executive Director of Medscheme, a major subsidiary of
AfroCentric
Date of transaction: 1 December 2025
Nature of transaction: Vesting of awards made under the 2017 Long Term
Incentive Plan in November 2020 and 2021, as well as the
2022 Forfeitable Share Scheme in November 2022, which
awards were due to vest in November 2025
Class of securities: Ordinary shares
Number of securities: 391 667
Notional value of transaction (based on R528 750.45
an implied price of R1.35 per share,
being the closing price on 28 November
2025)
Nature of interest: Direct Beneficial
Clearance obtained: Yes
Name of Director Fezeka Nompumza
Designation: Executive Director of Medscheme, a major subsidiary of
AfroCentric
Date of transaction: 1 December 2025
Nature of transaction: Vesting of awards made under the 2017 Long Term
Incentive Plan in November 2021, and the 2022 Forfeitable
Share Scheme in November 2022, which awards were due
to vest in November 2025
Class of securities: Ordinary shares
Number of securities: 308 333
Notional value of transaction (based on R416 249.55
an implied price of R1.35 per share,
being the closing price on 28 November
2025)
Nature of interest: Direct Beneficial
Clearance obtained: Yes
Johannesburg
11 December 2025
JSE Sponsor to AfroCentric
Questco Corporate Advisory Proprietary Limited